Aromatherapy might be able to improve memory and help treat depression.
Scents are more effective than words at cueing up the memory of a specific event, researchers report Feb. 13 in the journalThat could help depressed individuals shake negative thought cycles and rewire their thinking patterns, researchers said.
The scents ranged from oranges to ground coffee to shoe polish to the distinct eucalyptus sharpness of Vicks VapoRub.are less capable of drawing on specific memories from their lives, researchers said.because patients will repeat self-denigrating thoughts like “I am a failure” or “I fight with my friends a lot." They are unable to remember events that might demonstrate otherwise, researchers said.
“It was surprising to me that nobody thought to look at memory recall in depressed individuals using odor cues before,” Young said in a university news release.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Familiar scents unlock memories in people with depression. Could 'smell therapy' help patients?Aria Bendix is the breaking health reporter for NBC News Digital.
Read more »
Gene Therapy’s Promise Meets Nigeria’s Sickle Cell RealityThe U.S. FDA approved a breakthrough treatment for sickle cell anemia. But in Nigeria, social changes could make a bigger difference.
Read more »
Angiodema: Gene therapy blocks painful hereditary disorderA single dose of gene therapy was enough to stop the painful swelling attacks caused by angiodema.
Read more »
First-Ever CRISPR-Based Therapy Approved for Sickle Cell DiseaseU.S. patients with sickle cell disease now have a novel treatment option: the first-ever CRISPR-based therapy.for use in patients age 12 years and older. In addition to offering hope of relief for people with severe forms of the painful blood disorder, the treatment, called Casgevy, is the world’s first to genetically tweak cells using theAnother gene therapy for sickle cell disease, called Lyfgenia and developed by biotech company bluebird bio, based in Somerville, Mass., was also approved December 8. Getting a green light for the first CRISPR-based medicine is exciting, says David Altshuler, chief scientific officer at Boston-based Vertex Pharmaceuticals, which developed the drug in a joint venture with CRISPR Therapeutics, a company in Cambridge, Mass. But the fact that the drug fills an unmet need for underserved patients is “more compelling to me, personally, than the fact that it’s CRISPR.” , most of them Black or Latino, have sickle cell disease. It is caused by a genetic defect in hemoglobin, the oxygen-carrying protein in red blood cells
Read more »
With a nudge from Newsom, a new bill aims to legalize psychedelic-assisted therapy in CaliforniaAfter a failed attempt to decriminalize a short list of psychedelics last year, state Sen. Scott Wiener (D-San Francisco) is reintroducing legislation to make California the third state to legalize psychedelic-assisted therapy for adults.
Read more »
6 Therapy and Mental Health Resources for Black Women and GirlsThese expert-backed options will get you started on the path to healing.
Read more »